|
US3261761A
(en)
|
1962-05-07 |
1966-07-19 |
Arthur W Anderson |
Method of freeze drying bacterial cultures
|
|
US4205132A
(en)
|
1978-07-17 |
1980-05-27 |
Microlife Technics, Inc. |
Lyophilization of bacteria
|
|
EP0952773B1
(en)
|
1995-09-15 |
2005-11-23 |
Dale N. Gerding |
Methods and compositions for prevention and treatment of clostridium difficile-associated diseases
|
|
US6368586B1
(en)
|
1996-01-26 |
2002-04-09 |
Brown University Research Foundation |
Methods and compositions for enhancing the bioadhesive properties of polymers
|
|
AUPQ899700A0
(en)
*
|
2000-07-25 |
2000-08-17 |
Borody, Thomas Julius |
Probiotic recolonisation therapy
|
|
EP1815016B1
(en)
|
2004-11-01 |
2012-06-27 |
George Mason University |
Compositions and methods for diagnosing colon disorders
|
|
CN101171019B
(zh)
*
|
2005-03-03 |
2012-05-23 |
株式会社明治 |
免疫功能调节剂
|
|
WO2010036876A2
(en)
|
2008-09-25 |
2010-04-01 |
New York University |
Compositions and methods for characterizing and restoring gastrointestinal, skin, and nasal microbiota
|
|
GB0916335D0
(en)
*
|
2009-09-17 |
2009-10-28 |
Martin W J |
Medicaments
|
|
EP4663746A3
(en)
*
|
2010-02-01 |
2026-04-15 |
Ferring Microbiome Inc. |
Bacteriotherapy for clostridium difficile colitis
|
|
WO2011151941A1
(ja)
|
2010-06-04 |
2011-12-08 |
国立大学法人東京大学 |
制御性ｔ細胞の増殖または集積を誘導する作用を有する組成物
|
|
CA2807242C
(en)
|
2010-08-04 |
2017-05-02 |
Thomas Julius Borody |
Compositions for fecal floral transplantation and methods for making and using them and devices for delivering them
|
|
WO2012024638A2
(en)
|
2010-08-20 |
2012-02-23 |
New York University |
Compositions and methods for treating obesity and related disorders by characterizing and restoring mammalian bacterial microbiota
|
|
WO2012098358A1
(en)
|
2011-01-20 |
2012-07-26 |
Biopharma Technology Ltd |
Freeze drying method
|
|
CA2837081C
(en)
|
2011-05-23 |
2019-06-25 |
Washington State University Research Foundation |
Use of photosynthetic pigment stabilizing agents to regulate ripening and quality in fruits and vegetables
|
|
EP2756071B1
(en)
|
2011-09-14 |
2017-12-20 |
University Of Guelph |
Media supplements and methods to culture human gastrointestinal anaerobic microorganisms
|
|
CA2892588A1
(en)
|
2011-12-01 |
2013-06-06 |
School Corporation, Azabu Veterinary Medicine Educational Institution |
Human-derived bacteria that induce proliferation or accumulation of regulatory t cells
|
|
IN2014DN07752A
(enExample)
|
2012-02-29 |
2015-05-15 |
Ethicon Endo Surgery Inc |
|
|
JP6201982B2
(ja)
|
2012-03-30 |
2017-09-27 |
味の素株式会社 |
糖尿病誘起細菌
|
|
US10130665B2
(en)
|
2012-05-18 |
2018-11-20 |
Genome Research Limited |
Method for identifying bacteria for bacteriotherapy
|
|
CN102743420A
(zh)
|
2012-06-06 |
2012-10-24 |
上海交通大学 |
改善肠道菌群结构的方法及应用
|
|
WO2014029578A1
(en)
|
2012-08-24 |
2014-02-27 |
Haldor Topsøe A/S |
Method and catalyzed filter element with improved alkali-resistance for flue gas cleaning
|
|
MX2015006491A
(es)
|
2012-11-23 |
2015-12-03 |
Seres Health Inc |
Composiciones bacterianas sinergicas y metodos de produccion y uso de las mismas.
|
|
MX369877B
(es)
|
2013-02-04 |
2019-11-25 |
Seres Therapeutics Inc |
Composiciones y metodos.
|
|
US20160040215A1
(en)
|
2013-03-14 |
2016-02-11 |
Seres Therapeutics, Inc. |
Methods for Pathogen Detection and Enrichment from Materials and Compositions
|
|
US9907755B2
(en)
|
2013-03-14 |
2018-03-06 |
Therabiome, Llc |
Targeted gastrointestinal tract delivery of probiotic organisms and/or therapeutic agents
|
|
JP2016519664A
(ja)
|
2013-03-15 |
2016-07-07 |
セレス セラピューティクス インコーポレイテッド |
ネットワークを基にした微生物組成物及び方法
|
|
US9669059B2
(en)
|
2013-03-15 |
2017-06-06 |
University Of Florida Research Foundation, Incorporated |
Butyrogenic bacteria as probiotics to treat clostridium difficile
|
|
US9764019B2
(en)
|
2013-07-09 |
2017-09-19 |
Vedanta Biosciences, Inc. |
Compositions containing combinations of bioactive molecules derived from microbiota for treatment of disease
|
|
AU2014331610B2
(en)
|
2013-10-03 |
2019-11-07 |
Trustees Of The University Of Pennsylvania |
Compositions comprising a defined microbiome and methods of use thereof
|
|
MX367109B
(es)
|
2013-11-25 |
2019-08-05 |
Seres Therapeutics Inc |
Composiciones bacterianas sinergicas y sus metodos de produccion y usos.
|
|
US9956282B2
(en)
|
2013-12-16 |
2018-05-01 |
Seres Therapeutics, Inc. |
Bacterial compositions and methods of use thereof for treatment of immune system disorders
|
|
WO2015156419A1
(en)
|
2014-04-10 |
2015-10-15 |
Riken |
Compositions and methods for induction of th17 cells
|
|
EP3134509B1
(en)
|
2014-04-23 |
2026-01-21 |
Cornell University |
Modulation of fat storage in a subject by altering population levels of christensenellaceae in the gi tract
|
|
EP3146065B1
(en)
|
2014-05-19 |
2024-11-13 |
Memorial Sloan Kettering Cancer Center |
Methods and compositions for reducing clostridium difficile infection
|
|
EP4529950A3
(en)
|
2014-10-31 |
2025-08-20 |
Pendulum Therapeutics, Inc. |
Methods and compositions relating to microbial treatment
|
|
MA41020A
(fr)
|
2014-11-25 |
2017-10-03 |
Evelo Biosciences Inc |
Compositions probiotiques et prébiotiques, et leurs procédés d'utilisation pour la modulation du microbiome
|
|
ES3010296T3
(en)
|
2014-11-25 |
2025-04-02 |
Memorial Sloan Kettering Cancer Center |
Intestinal microbiota and gvhd
|
|
CN114159476A
(zh)
|
2015-05-14 |
2022-03-11 |
克雷斯顿沃控股公司 |
用于粪便菌群移植的组合物以及用于制备和使用它们的方法和用于递送它们的装置
|
|
EP3297727A1
(en)
|
2015-05-21 |
2018-03-28 |
Yeda Research and Development Co. Ltd |
Bacterial populations for promoting health
|
|
US20180153944A1
(en)
|
2015-06-09 |
2018-06-07 |
Regents Of The University Of Minnesota |
Methods for detecting risk of having a bloodstream infection and compositions for reducing the risk
|
|
EP3662917A1
(en)
|
2015-06-15 |
2020-06-10 |
4D Pharma Research Limited |
Compositions comprising bacterial strains
|
|
LT3360559T
(lt)
|
2015-06-15 |
2019-12-27 |
4D Pharma Research Limited |
Kompozicijos, apimančios bakterijų kamienus
|
|
MA41010B1
(fr)
|
2015-06-15 |
2020-01-31 |
4D Pharma Res Ltd |
Compositions comprenant des souches bactériennes
|
|
PE20180243A1
(es)
|
2015-06-15 |
2018-01-31 |
4D Pharma Res Ltd |
Composiciones que comprenden cepas bacterianas
|
|
MA41060B1
(fr)
|
2015-06-15 |
2019-11-29 |
4D Pharma Res Ltd |
Compositions comprenant des souches bactériennes
|
|
EA201890097A1
(ru)
|
2015-06-22 |
2018-07-31 |
Президент Энд Феллоуз Оф Гарвард Колледж |
Индукция регуляторных т-клеток lamina propria
|
|
US20180200308A1
(en)
|
2015-07-08 |
2018-07-19 |
Seres Therapeutics, Inc. |
Methods of treating colitis
|
|
WO2017035188A1
(en)
|
2015-08-24 |
2017-03-02 |
Nubyiota Llc |
Systems and methods for treating a dysbiosis using fecal-derived bacterial populations
|
|
EP3368050A1
(en)
|
2015-10-26 |
2018-09-05 |
Crestovo Holdings LLC |
Compositions and methods for fecal microbiota-related therapy
|
|
MA41013A
(fr)
|
2015-11-20 |
2017-08-30 |
4D Pharma Res Ltd |
Compositions comprenant des souches bactériennes
|
|
GB201520497D0
(en)
|
2015-11-20 |
2016-01-06 |
4D Pharma Res Ltd |
Compositions comprising bacterial strains
|
|
GB201520638D0
(en)
|
2015-11-23 |
2016-01-06 |
4D Pharma Res Ltd |
Compositions comprising bacterial strains
|
|
GB201520631D0
(en)
|
2015-11-23 |
2016-01-06 |
4D Pharma Res Ltd |
Compositions comprising bacterial strains
|
|
US20190247447A1
(en)
|
2015-11-24 |
2019-08-15 |
Seres Therapeutics, Inc. |
Designed bacterial compositions
|
|
MX373290B
(es)
|
2016-03-04 |
2020-06-18 |
4D Pharma Plc |
Composiciones que comprenden cepas bacterianas.
|
|
US20170290889A1
(en)
|
2016-04-11 |
2017-10-12 |
New York University |
Methods and compositions for treating dysbiosis and gastrointestinal and inflammatory disorders
|
|
KR102658297B1
(ko)
|
2016-06-14 |
2024-04-18 |
베단타 바이오사이언시즈, 인크. |
클로스트리디움 디피실레 감염의 치료
|
|
WO2018005606A1
(en)
*
|
2016-06-28 |
2018-01-04 |
Synthetic Biologics, Inc. |
Microbiome protection from oral antibiotics
|
|
WO2018080477A1
(en)
*
|
2016-10-26 |
2018-05-03 |
The Joan & Irwin Jacobs Technion-Cornell Institute |
Systems and methods for ultra-fast identification and abundance estimates of microorganisms using a kmer-depth based approach and privacy-preserving protocols
|
|
US11447738B2
(en)
|
2016-10-28 |
2022-09-20 |
Vedanta Biosciences, Inc. |
Methods and compositions for preserving bacteria
|
|
US20200061131A1
(en)
|
2016-12-16 |
2020-02-27 |
Vedanta Biosciences, Inc. |
Methods and compositions for determining bacterial integrity
|
|
AU2018365071B2
(en)
|
2017-11-09 |
2025-09-11 |
Vedanta Biosciences, Inc. |
Compositions and methods for the treatment of allergy
|
|
KR20210024481A
(ko)
|
2018-05-24 |
2021-03-05 |
세레스 테라퓨틱스, 인코포레이티드 |
설계된 박테리아 조성물 및 이의 용도
|
|
JP7558170B2
(ja)
|
2018-08-17 |
2024-09-30 |
ヴェダンタ バイオサイエンシーズ インコーポレーテッド |
腸内毒素症を減少させ、微生物叢を復元する方法
|
|
WO2022159711A1
(en)
|
2021-01-21 |
2022-07-28 |
Vedanta Biosciences, Inc. |
Compositions and methods for treating hepatic encephalopathy
|